Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Ticagrelor on Endothelial Function
NCT01805596Phase 3Completed
- Start
- Apr 2013
- Primary completion
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ticagrelor in coronary artery disease (CAD). Started Apr 2013; status: completed.
02
Drugs
ticagrelor
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT01805596.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01805596.